Parameters on esophageal ph-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 5, 2015, Pages 884-891

  Patel, Amit ^a   Sayuk, Gregory S ^a   Gyawali, C Prakash ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Esophageal pH Impedance monitoring; GERD; PPI; Response to therapy; Symptom Reflux correlation

Indexed keywords

PROTON PUMP INHIBITOR;

ABDOMINAL SURGERY; ACID EXPOSURE TIME; ADULT; ARTICLE; DOMINANT SYMPTOM INTENSITY; ESOPHAGUS PH; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GLOBAL SYMPTOM SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; QUESTIONNAIRE; REFLUX EXPOSURE TIME; TIME; UNIVARIATE ANALYSIS; ESOPHAGEAL PH MONITORING; MIDDLE AGED; MISSOURI; PATHOLOGY; PROGNOSIS; TREATMENT OUTCOME;

ESOPHAGEAL PH MONITORING; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; MISSOURI; PROGNOSIS; PROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84927911325     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.08.029     Document Type: Article

References (29)

1. Bredenoord A.J., Weusten B.L., Timmer R., et al. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy. Am J Gastroenterol 2006, 101:453-459.
2. Zerbib F., Roman S., Ropert A., et al. Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy. Am J Gastroenterol 2006, 101:1956-1963.
3. Pritchett J.M., Aslam M., Slaughter J.C., et al. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy. Clin Gastroenterol Hepatol 2009, 7:743-748.
4. Patel A., Sayuk G.S., Gyawali C.P. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters. Am J Gastroenterol 2014, 109:836-844.
5. Hemmink G.J., Bredenoord A.J., Weusten B.L., et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?. Am J Gastroenterol 2008, 103:2446-2453.
6. Pandolfino J.E., Vela M.F. Esophageal-reflux monitoring. Gastrointest Endosc 2009, 69:917-930. 930 e1.
7. Ates F., Vaezi M.F. New approaches to management of PPI-refractory gastroesophageal reflux disease. Curr Treat Options Gastroenterol 2014, 12:18-33.
8. Vela M.F., Camacho-Lobato L., Srinivasan R., et al. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology 2001, 120:1599-1606.
9. Roman S., Poncet G., Serraj I., et al. Characterization of reflux events after fundoplication using combined impedance-pH recording. Br J Surg 2007, 94:48-52.
10. Frazzoni M., Conigliaro R., Melotti G. Reflux parameters as modified by laparoscopic fundoplication in 40 patients with heartburn/regurgitation persisting despite PPI therapy: a study using impedance-pH monitoring. Dig Dis Sci 2011, 56:1099-1106.
11. Mainie I., Tutuian R., Agrawal A., et al. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006, 93:1483-1487.
12. del Genio G., Tolone S., del Genio F., et al. Prospective assessment of patient selection for antireflux surgery by combined multichannel intraluminal impedance pH monitoring. JGastrointest Surg 2008, 12:1491-1496.
13. Stoikes N., Drapekin J., Kushnir V., et al. The value of multiple rapid swallows during preoperative esophageal manometry before laparoscopic antireflux surgery. Surg Endosc 2012, 26:3401-3407.
14. Reidel W.L., Clouse R.E. Variations in clinical presentation of patients with esophageal contraction abnormalities. Dig Dis Sci 1985, 30:1065-1071.
15. Kushnir V.M., Prakash Gyawali C. High resolution manometry patterns distinguish acid sensitivity in non-cardiac chest pain. Neurogastroenterol Motil 2011, 23:1066-1072.
16. Shay S., Tutuian R., Sifrim D., et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol 2004, 99:1037-1043.
17. Wiener G.J., Richter J.E., Copper J.B., et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988, 83:358-361.
18. Ghillebert G., Janssens J., Vantrappen G., et al. Ambulatory 24 hour intraoesophageal pH and pressure recordings v provocation tests in the diagnosis of chest pain of oesophageal origin. Gut 1990, 31:738-744.
19. Weusten B.L., Roelofs J.M., Akkermans L.M., et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994, 107:1741-1745.
20. Prakash C., Clouse R.E. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2005, 3:329-334.
21. Kushnir V.M., Sayuk G.S., Gyawali C.P. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain. Am J Gastroenterol 2010, 105:1032-1038.
22. Kushnir V.M., Sathyamurthy A., Drapekin J., et al. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring. Aliment Pharmacol Ther 2012, 35:1080-1087.
23. Vaezi M.F., Richter J.E. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996, 111:1192-1199.
24. Aanen M.C., Weusten B.L., Numans M.E., et al. Effect of proton-pump inhibitor treatment on symptoms and quality of life in GERD patients depends on the symptom-reflux association. JClin Gastroenterol 2008, 42:441-447.
25. Campos G.M., Peters J.H., DeMeester T.R., et al. Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. JGastrointest Surg 1999, 3:292-300.
26. Zerbib F., Belhocine K., Simon M., et al. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut 2012, 61:501-506.
27. Moawad F.J., Betteridge J.D., Boger J.A., et al. Reflux episodes detected by impedance in patients on and off esomeprazole: a randomised double-blinded placebo-controlled crossover study. Aliment Pharmacol Ther 2013, 37:1011-1018.
28. Slaughter J.C., Goutte M., Rymer J.A., et al. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2011, 9:868-874.
29. Hersh M.J., Sayuk G.S., Gyawali C.P. Long-term therapeutic outcome of patients undergoing ambulatory pH monitoring for chronic unexplained cough. JClin Gastroenterol 2010, 44:254-260.